1. Home
  2. ACHV

as of 02-26-2026 2:32pm EST

$4.65
+$0.03
+0.65%
Stocks Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances Nasdaq

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Founded: N/A Country:
United States
United States
Employees: N/A City: SEATTLE
Market Cap: 233.7M IPO Year: 2018
Target Price: $15.50 AVG Volume (30 days): 464.6K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.99 EPS Growth: 17.33
52 Week Low/High: $1.84 - $6.03 Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: -4.67 Index: N/A
Free Cash Flow: -29791000.0 FCF Growth: N/A

Share on Social Networks: